Hormone Receptor-Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices.

Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor-positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.